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It has been suggested recently that arsenic– glutathione (As–GSH) complexes play an
important role in the methylation of arsenic. The present study describes the development
of high-performance liquid chromatography (HPLC)-electrospray tandem mass spectrom-
etry (ES-MS/MS), operated in the selected reaction monitoring (SRM) mode, and HPLC-
inductively coupled plasma mass spectrometry (ICP-MS) methods suitable for the sensitive and
selective identification of four As–GSH complexes. Method optimization was carried out using a
series of synthetically prepared standards, i.e., three As–GSH species containing trivalent arsenic:
tri(glutamyl-cysteinyl-glycinyl)trithio-arsenite ( ATG), di(glutamyl-cysteinyl-glycinyl)methyl-
dithio-arsonite (MADG), and (ã-glutamyl-cysteinyl-glycinyl) dimethyl-thio-arsinite (DMAG), as
well as one As–GSH species containing pentavalent As: dimethylthioarsinic acid-glutathione
(DMTAV –GSH). The collision induced dissociation behavior of these compounds was
investigated in detail to identify optimum SRM transitions for each complex. Both methods
were based on reversed-phase chromatography using gradient elution with methanol,
formic acid, and water as solvents. The amount of methanol that was used with this HPLC
method (up to 12% vol/vol) was compatible with ICP-MS, without the need of a specially
adapted interface. Subsequently, these analytical methods were applied to carry out a
preliminary investigation about the role of As–GSH complexes in the methylation of
arsenite by methylcobalamin (CH3 B 12) in the presence of glutathione (GSH). For the first
time, the complexes ATG, MADG, and trace amounts of DMAG were detected as products
of this reaction. (J Am Soc Mass Spectrom 2008, 19, 1559 –1567) © 2008 American Society
for Mass SpectrometryWorldwide, several millions of people are nowaffected by elevated arsenic levels in theirdrinking water [1]. The predominant forms of
arsenic in drinking water are arsenite and arsenate
(iAsIII and iAsV, respectively), the inorganic species
which are regarded as human carcinogens [2, 3]. Inor-
ganic arsenic compounds are transformed in the body
by repetitive reduction and oxidative methylation reac-
tions, leading to the formation of organoarsenic species,
the major of which are monomethylarsonic acid
(MMAV) and dimethylarsinic acid (DMAV) [3, 4].
The precise pathway through which inorganic ar-
senic is metabolized in the organism is not yet known in
sufficient detail. The generally accepted methylation
mechanism involves the initial conversion of pentavalent
arsenic species iAsV to trivalent species iAsIII through a
two-electron reduction, while oxidative addition of a
methyl group follows [4, 5]. Glutathione (GSH) can act as
a reducing agent and S-adenosylmethionine (SAM) as a
methyl donor. The major site for the methylation seems to
be the liver. However, Hayakawa et al. recently proposed
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doi:10.1016/j.jasms.2008.06.011an alternative mechanism for the methylation of inorganic
arsenic in biological systems [6]. According to this meth-
ylation mechanism, complexes of arsenic with glutathione
(As–GSH) are believed to play an essential role in the
metabolism and transport of inorganic arsenic within an
organism.
Arsenic has a strong affinity for sulfur as indicated
by the numerous As-S compounds containing pentava-
lent arsenic that have been identified in biological
samples recently [7–10]. However, most of these As–S
species comprise small molecules that do not contain
amino acids. So far, only a few arsenic-peptide species,
formed via As–S bonds, have been identified in vivo,
such as a series of arsenic phytochelatin complexes in
plants [11] and arsenic glutathione complexes in bile
and urine [12–15], all of which contain trivalent arsenic.
The first study which showed that pentavalent arsenic
can also bind to biomolecules was published in 2007 by
Feldmann et al. [16]. This study demonstrated the
formation of the pentavalent dimethylthioarsinic acid–
glutathione complex (DMTAV–GSH) in cabbage (Bras-
sica oleracea) when exposed to DMAV. This finding not
only changes the view of how arsenic may interact with
other sulfur-rich biomolecules, but also highlights the
fact that As–S interactions may have a key role in the
reactivity of arsenic intermediates and the metabolic
pathway of arsenic in an organism.
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conjugates are not stable under the conventional chro-
matographic methods used in arsenic speciation analy-
sis involving As species having As–C and As–O bonds.
More specifically, it has been reported that these As–
GSH complexes decompose on the PRPX-100 anion
exchange HPLC column, when carbonate or formic acid
buffers are used [17]. This is most likely the reason that
has made their detection in biological tissues so prob-
lematic. On the other hand, the fact that no precautions
are usually taken during extraction procedures to pre-
vent their oxidation may have also contributed to their
late detection.
The first attempts to detect and characterize triva-
lent As–GSH complexes were based on nuclear mag-
netic resonance (NMR) spectroscopy, by observing the
chemical shifts of the proton (1H) and the carbon-
13 (13C) nuclei [18, 19]. This technique led to the
identification of the synthetically derived ATG [tri-
(glutamyl-cysteinyl-glycinyl)trithio-arsenite], MADG
[di(glutamyl-cysteinyl-glycinyl)methyl-dithio-arsonite], and
DMAG [(ã-glutamyl-cysteinyl-glycinyl)dimethyl-thio-
arsinite] complexes, which were derived from the reac-
tion of iAsIII, MMAV, and DMAV, respectively, with
GSH. Subsequently, thin-layer chromatography (TLC)
using radiolabeled arsenicals with the isotope 73As was
applied for the identification of the specific complexes
[20, 21]. However, both of these techniques do not offer
the sensitivity and selectivity that is demanded for the
detection of the species at the low g/L level that they
may be found in biological samples. In addition, “open
column liquid chromatographic” techniques do not
ensure the stability of the analyzed compounds, while
the use of radioactive isotopes, such as 73As, is techni-
cally quite complicated and generally not desirable.
For these reasons, researchers attempted to improve
the existing analytical capabilities by using modern
state-of-the-art analytical techniques, such as high-
performance liquid chromatography (HPLC)-inductively
coupled plasma mass spectrometry (ICP-MS) and
HPLC-electrospray tandem mass spectrometry (ES-
MS/MS). Kala et al., using reversed-phase chromatog-
raphy in combination with ICP-MS and ES-MS (in
selected ion monitoring mode), managed to identify
the complexes ATG and MADG in rat’s bile after the
administration of sodium arsenite [12]. However, the
separation under these conditions was not sufficient,
which is a significant disadvantage during the analysis
with HPLC-ICP-MS. In subsequent studies, the chroma-
tography was improved, giving well-defined and fully
separated peaks for the three As–GSH complexes (ATG,
MADG, and DMAG), during analysis with both
ICP-MS and ES-MS [17]. Although the ES-MS technique
has been used for the identification of trivalent As–GSH
complexes in standard solutions as well as in biological
samples, by facilitating the observation of m/z values
corresponding to precursor molecular ions, only one
study up to now uses tandem spectrometry (MS/MS) to
obtain additional structural information regarding thecompounds of interest [22]. Nevertheless, since this
study did not focus on arsenic, only a few fragment ions
were presented. With respect to the pentavalent As–GSH
complex (DMTAV–GSH), its identification has been car-
ried out using reversed-phase HPLC coupled simulta-
neously to ES-MS/MS and ICP-MS detectors [16].
In the present study, emphasis was given to the
development of a HPLC-ES-MS/MS method in selected
reaction monitoring (SRM) mode suitable for the simul-
taneous detection and characterization of the three
trivalent As–GSH complexes, i.e., ATG, MADG, and
DMAG, as well as the one pentavalent As–GSH com-
plex (DMTAV–GSH). SRM was chosen as a very sensi-
tive and selective approach that allows for interference-
free identification of analytes at the low g/L level even
in crude biological extracts containing high levels of
matrix. The presence of the four As–GSH species was
further confirmed using HPLC-inductively coupled
plasma mass spectrometry (ICP-MS). It is envisioned
that because of their sensitivity and selectivity, this
combination of techniques may potentially be used to
investigate the presence of As–GSH species in crude
biological samples. Both methods were based on
reversed-phase chromatography with gradient elu-
tion, which allows for the efficient elution of the
complexes from the column and their sufficient
separation.
The HPLC-ICP-MS and HPLC-ES-MS/MS methods
developed in this study were further used to investigate
the formation of As–GSH species in arsenic methylation
reactions, in particular for investigating the nonenzy-
matic methylation of arsenite by methylcobalamin in
the presence of glutathione. This reaction has previ-
ously been studied, although the presence of As–GSH
conjugates amongst the reaction products has not been
reported until now [23, 24].
Experimental
Chemicals
Sodium arsenite (NaAsO2) was purchased from BDH
Ltd., Poole, United Kingdom. Monosodium acid
methane arsonate sesquihydrate (purity 99%) was pur-
chased from Supelco (Bellefonte, PA). Cacodylic acid
(C2H7AsO2, puriss.  99%), L-glutathione reduced
(C10H17N3O6S, puriss.  97%), tris (hydroxymethyl)
aminomethane hydrochloride (C4H11NO3 · HCl, ultra
for molecular biology), formic acid (CH2O2, puriss.
p.a. ACS; 88%–91% {T}), and ammonium hydroxide
solution (NH5O, puriss., p.a.) were purchased from
Fluka Chemika, Buchs, Switzerland. Methylcobalamin
(C63H91CoN13O14P) and methanol (CH3OH, for gradi-
ent elution ACS) were purchased from Sigma (Buchs,
Switzerland). Hydrochloric acid (HCl, 37%, puriss.,
p.a.) and iron(II) sulfide sticks (FeIIS) were obtained
from Riedel-de Haen, Seelze, Germany.
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The synthesis of ATG, MADG, DMAG, and DMTAV–
GSH complexes was based on previously published
procedures [12, 16, 18]. With respect to the trivalent
As–GSH complexes (ATG, MADG, and DMAG) the
reaction solution was left at room temperature over-
night under an argon atmosphere, with continuous
stirring.
More specifically, ATG was prepared by dissolv-
ing sodium arsenite (0.037 g; 0.28 mmol) and GSH
reduced (0.26 g; 0.85 mmol) in 2.5 mL of degassed
deionized water. At the end of the reaction, the
product was precipitated with 10 mL methanol. The
precipitate was centrifuged, and following the re-
moval of the supernatant, the residue was dried at
room temperature.
Similarly, MADG was prepared by dissolving
monosodium acid methane arsonate (0.059 g, 0.36
mmol) and GSH (0.5 g, 1.63 mmol) in 2 mL of
degassed deionized water. At the end of the reaction,
the product was precipitated with 10 mL ethanol. The
precipitate was centrifuged, and following the re-
moval of the supernatant, the residue was dried at
room temperature.
For DMAG preparation, cacodylic acid (0.035 g; 0.25
mmol) and GSH (0.23 g; 0.75 mmol) were dissolved in
2.5 mL of degassed deionized water. At the end of the
reaction, the product was precipitated with 10 mL of
methanol. The precipitate was centrifuged, and follow-
ing the removal of the supernatant the residue was
dried at room temperature.
Following the synthesis of the trivalent As–GSH
complexes, as described previously, the dried solid
corresponding to each complex was reconstituted in 1
mL of 0.1% formic acid solution and then diluted
further before analysis with HPLC-ES-MS/MS and
HPLC-ICP-MS.
With respect to the synthesis of the pentavalent As
containing compound DMTAV–GSH, initially a solu-
tion containing dimethylthioarsinic acid (DMTAV) was
prepared by treating a DMAV containing solution (10
ppm) with H2S (which resulted from the reaction of
FeIIS with hydrochloric acid). Then, equal volumes of a
GSH containing solution (214 mM) and a DMTAV
containing solution were mixed and left to react for 45
min before analysis using HPLC-ICP-MS and HPLC-
ES-MS/MS.
Arsenite Methylation Reaction
To investigate the methylation of arsenite by methylco-
balamin (CH3B12) in the presence of GSH, a solution
containing 0.06 M tris buffer (pH 7.8), 45 mM GSH
reduced, and 16 ppm sodium arsenite was prepared.
The mixture was left to stand under an argon atmo-
sphere for 45 min at 37 °C before adding the methylco-
balamin solution (giving a final concentration of 0.17
mM methylcobalamin in the reaction solution). Micro-liter aliquots were taken from the reaction mixture at
various time intervals, and analyzed immediately with
and without dilution by using HPLC-ICP-MS and
HPLC-ES-MS/MS.
Instrumentation
For the HPLC-ES-MS/MS method, a triple quadru-
pole TSQ Quantum mass spectrometer (Thermo
Finnigan, San Jose, CA) was used with an electros-
pray ion source in the positive ion mode. The opti-
mum tune parameters were the following: electros-
pray voltage 4.1 kV, sheath gas pressure 45 arbitrary
units, auxiliary gas pressure 25 arbitrary units, cap-
illary temperature 300 °C, source collision-induced
dissociation (CID) 0 V.
For the HPLC-ICP-MS method, an X-series ICP mass
spectrometer was used (Thermo Fischer Scientific,
Winsford, United Kingdom) to monitor ions at m/z 75
(As) and m/z 77 (ArCl). The optimum tune parameters
used were the following: forward power 1400 W, neb-
ulizer gas flow rate 1.0 mL/min, cooling gas flow rate
13.5 L/min, auxiliary gas flow rate 1.0 L/min, lens 1
voltage 0.6 V, extraction lens voltage 196 V.
For both methods, reversed-phase chromatography
with a BDS hypersil C18 chromatographic column (150
mm  2.1 mm, 5-m particle size, Thermo) and a BDS
Hypersil C18 precolumn (Thermo) was applied. After
trying several different HPLC gradient modes using
various amounts of methanol and formic acid in the
mobile phase, a set of optimum mobile phase condi-
tions was reached, and gradient elution was performed
using a combination of 0.05% vol/vol concentrated (d
1.20 g/mL) formic acid in 2% vol/vol aqueous metha-
nol at pH  3 (Eluent A) and 100% vol/vol methanol
(Eluent B). The gradient was performed using an
LC20-AD Prominence solvent delivery system (Shi-
madzu Corp., Kyoto, Japan). The detailed gradient
program was as follows: 0–10 min 100% Eluent A and
0% Eluent B; 10–11 min changed to 90% Eluent A and
10% Eluent B; 11–30 min constant at 90% Eluent A and
10% Eluent B; 31–40 min changed to 100% Eluent A.
The HPLC flow rate both for HPLC-ES-MS/MS and
HPLC-ICP-MS methods was 0.2 mL/min. With respect
to the ES-MS/MS, 100% of the eluent was directed to
the ES source, while in the case of ICP-MS, there was a
post column make-up flow of dilute nitric acid (2%
vol/vol) delivered via a peristaltic pump (0.9 mL/
min). The role of the make-up flow was first to further
dilute the organic content of the eluent (methanol) and
then to increase the flow introduced to the ICP to have
efficient nebulization.
With this optimized method, the complete separa-
tion of all four As–GSH complexes was achieved, with
sharp and well defined peaks, while retention times
corresponding to the complexes were stable and iden-
tical for both standards and samples.
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Development of an HPLC-ES-MS/MS Method for
the Identification of As–GSH Complexes
Product ion scan. Reversed-phase HPLC-ES-MS/MS
experiments were conducted to characterize the As–
GSH content of all the standard solutions prepared in
the present study. For this reason, initially, product ion
scanning in the positive ion mode was applied for the
analysis of standard solutions containing the As–GSH
complexes (ATG, MADG, DMAG, and DMTAV–GSH),
GSH, and DMAV. In each of these product ion scans, the
protonated molecule corresponding to each compound
was selected as the precursor ion. The expected m/z
ratios for the protonated molecules of ATG, MADG,
DMAG, DMTAV–GSH, GSH, and DMAV are m/z 994,
703, 412, 444, 308, and 139, respectively. Upon collision
induced dissociation (CID) of the precursor ions at
various collision energies (5, 15, 25, 35, 45, and 60 eV),
the product ion mass spectra corresponding to each of
these species were recorded. Representative product
ion mass spectra of the four As–GSH species are shown
in Figure 1. Moreover, the mass spectra of DMAV and
GSH are presented as Supplementary Figure 1, which
can be found in the electronic version of this article. The
Figure 1. Product ion mass spectra of the proto
and (d) DMTAV–GSH.CID breakdown curves corresponding to these com-
pounds, displaying the absolute intensities of the major
product ions as a function of the collision energy, are
shown in Supplementary Figure 2. The mass spectra of
all the species revealed the presence of characteristic
product ions. The proposed structures of the product
ions corresponding to the four As–GSH species are
shown in Scheme 1, while the proposed structures of
the product ions corresponding to DMAV and GSH are
presented in Supplementary Scheme 1.
Because of the low sensitivity observed for MMAV
under positive ion electrospray ionization conditions,
we were not able to obtain product ion scanning data
for this compound, so previously published SRM tran-
sitions were used [25].
Figure 1a presents the tandem mass spectrum of the
protonated molecule having m/z 994, which corre-
sponds to the protonated ATG complex. At collision
energy 25 eV, apart from observing the precursor
molecular ion (m/z 994), a product ion at m/z 687 also
predominates. The latter derives from the precursor ion
following the elimination of a GSH molecule. Other
notable product ions are those having m/z 308 (which
corresponds to the protonated GSH molecule), 380
(which arises from the product ion with m/z 687 after
molecules of: (a) ATG, (b) MADG, (c) DMAG,nated
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results from the product ion with m/z 380 after the loss
of glutamic acid). The suggested CID pathways of these
complexes are shown in Scheme 1a. The loss of glutamic
acid is typical for the CID of GSH. Other observed
product ions are the ones with m/z 558, which derive
from the ions withm/z 687 after the loss of glutamic acid
(Scheme 1a).
Figure 1b presents the tandem mass spectrum of the
protonated molecule with m/z 703, which corresponds
to MADG. The CID behavior of this species is similar to
that of ATG, which was presented previously. At a
collision energy of 25 eV, the product ion with m/z 396
predominates, and is believed to derive from the pre-
cursor ion following the loss of a GSH molecule. The
product ion with m/z 308, which corresponds to the
protonated molecule of GSH, is also observed under
these MS/MS conditions. The fragment ions with m/z
a AsGS
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Scheme 1. Collision induced dissociation (CID
(d) DMTAV–GSH.267 and 179, resulting from the product ions with m/z396 and 308, respectively, following the elimination of
glutamic acid, were also observed (Scheme 1b). Finally,
other observed product ions are those with m/z 164 as
shown in Figure 1b.
The tandem mass spectrum of the protonated mole-
cule with m/z 412, which corresponds to the complex
DMAG, are shown in Figure 1c. At a collision energy of
25 eV, the product ions with m/z 283, 266, 180, 155, and
137 predominate. The former product ion is believed to
result from the precursor ion following the loss of
glutamic acid, while its further fragmentation leads to
the removal of a OH group and the formation of an
ion with m/z 266. The product ion with m/z 337 results
from the precursor ion after the loss of a glycine
molecule. Finally, the product ions with m/z 180, 155,
and 137 have the structures suggested in Scheme 1c.
Figure 1d presents the tandem mass spectrum of the
protonated molecule with m/z 444, which corresponds
b
AsGS
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H
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) behto DMTAV–GSH. This mass spectrum revealed an
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loss of glutamic acid from the precursor ion. Other
product ions observed occur at m/z 231 [which results
from the precursor ion after the loss of a glycine
molecule and the (CH3)2AsSH moiety] and 177 [which
results from the product ion with m/z 315, after the loss
of the (CH3)2AsSH moiety]. The resulting product ion
mass spectra for this compound agree with the ones
reported by Feldmann et al. [16]. The interpretation of
these mass spectra is provided in Scheme 1d.
Supplementary Figure 1a presents the mass spectra
of the protonated molecule with m/z 308, which corre-
sponds to GSH. These spectra revealed abundant spe-
cies of m/z 179 and 233, which resulted from the
precursor ion after the elimination of glutamic acid and
glycine respectively. From the ion with m/z 179, after
further fragmentation and removal of a OH group,
the product ion with m/z 162 resulted. Other fragment
ions that are observed are the ones at m/z 144, 116, and
76 (Supplementary Scheme 1a).
Finally, in Supplementary Figure 1b the mass spectra
of the protonated DMAV molecule with m/z 139 are
presented. The interpretation of these spectra is de-
scribed in Supplementary Scheme 1b.
Selected reaction monitoring (SRM). The breakdown
curves provided as Supplementary Figure 2 were used
to find the most efficient conditions for generating
characteristic product ions for each arsenic species and
for GSH to be used in the selected reaction monitoring
(SRM) mode. The SRM approach is invaluable as it
enables sensitive and selective detection, if appropriate
conditions are used. The SRM conditions were opti-
mized for each analyte by selecting the most abundant
product ions with their corresponding optimum colli-
sion energies. From the CID breakdown curves ob-
tained in this study, the two most efficient fragmenta-
tion reactions were selected for each arsenic species and
for GSH (Table 1). However, for the detection of MMAV
only one SRM transition was used, as presented in a
previous study [25].
Using the HPLC-ES-MS/MS method in the SRM
mode, a standard solution containing all four As–GSH
complexes (ATG, MADG, DMAG, and DMTAV–GSH),
Table 1. SRM conditions used for the detection of three
As-GSH complexes, GSH, MMAV, and DMAV
Selected reactions monitored (collision
energy/eV)
SRM transition 1 SRM transition 2
MMAV 141 ¡ 91 (30 eV) -
DMAV 139 ¡ 91 (25 eV) 139 ¡ 109 (25 eV)
GSH 308 ¡ 179 (15 eV) 308 ¡ 162 (15 eV)
ATG 994 ¡ 308 (35 eV) 994 ¡ 687 (25 eV)
MADG 703 ¡ 308 (17 eV) 703 ¡ 396 (25 eV)
DMAG 412 ¡ 137 (35 eV) 412 ¡ 155 (25 eV)
VDMTA -GSH 444 ¡ 315 (15 eV) 444 ¡ 177 (25 eV)along with MMAV, DMAV, and GSH, was analyzed.
The resulting chromatogram (Figure 2) revealed the
presence of all seven species contained in the mixture,
with all four As–GSH complexes being well resolved.
Subsequently, an aliquot removed from the arsenite
CH3 B12 methylation reaction mixture after 4.5 h of
reaction was analyzed under the same HPLC-ES-MS/
MS-SRM conditions. The resulting chromatogram,
shown in Figure 3, revealed the presence of ATG (20.77
min) and MADG (25.39 min) complexes, while a small
peak corresponding to DMAG (35.50 min) was also
observed. In the same chromatogram, the presence of
large amounts of GSH is also obvious. Peaks for the
DMAV and MMAV were not observed, which may be
due to the low sensitivity exhibited for these two
species in positive ion mode ES-MS/MS.
Subsequently, a “blank” methylation reaction mix-
ture (i.e., no arsenic added to the reaction mixture) was
analyzed to exclude the possibility that the peaks attrib-
uted to ATG, MADG, and DMAG in the arsenite
Figure 2. HPLC-ES-MS/MS-SRM chromatogram of a standard
solution containing: DMAV, MMAV, GSH, ATG (35 g/mL),
MADG (12 g/mL), DMAG (9 g/mL), and DMTAV–GSH (0.22
g/mL).
Figure 3. HPLC-ES-MS/MS-SRM chromatogram of the arsenite
methylation reaction mixture after 4.5 h incubation at 37 °C.
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was in fact observed in the “blank” mixture.
A major advantage of the detection of arsenic species
by HPLC-ES-MS/MS in the SRM mode is that stan-
dards are not a prerequisite. The detailed CID data
reported here can be used by other researchers, without
the need for standards, to detect the presence of such
As–GSH complexes.
Development of a HPLC-ICP-MS Method for the
Identification of As–GSH Complexes
After the development of the HPLC-ES-MS/MS method
for the detection and characterization of the As–GSH
conjugates, attempts were made to apply the same
HPLC method with ICP-MS detection. The solvents
applied with the HPLC-ES-MS/MS technique were
compatible with the ICP-MS. The methanol that was
used did not exceed 12% vol/vol, an amount that was
further diluted using a make-up flow before introduc-
tion into the ICP-MS nebulizer.
Initially, standard solutions of As–GSH complexes
were analyzed using this approach, and the resulting
chromatograms are shown in Figure 4. The observed
retention times for the four As–GSH complexes are
similar to the ones observed during the analysis of the
standard solutions with HPLC-ES-MS/MS. Some vari-
ation may be attributable to the different HPLC instru-
mentation used in each case. The ATG, MADG, DMAG,
and DMTAV–GSH species correspond to the peaks with
retention times 20.2 min, 24.8 min, 34.7 min, and 19.0
Figure 4. Reversed-phase HPLC-ICP-MS chro
g/mL), (b) MADG (0.58 g/mL), (c) DMAG (2
other observed peaks in each chromatogram correspmin, respectively. Because the standard solutions were
not further purified, arsenic containing impurities were
observed.
Subsequently, aliquots of the arsenite CH3 B12 meth-
ylation mixture, removed after 2 and 3.5 h, were ana-
lyzed with this method, and the resulting chromato-
grams are shown in Figure 5. In Figure 5a, a
chromatogram of the nondiluted sample taken after 2 h
incubation at 37 °C is presented. Because the concentra-
tion of the ATG complex is very high and to prevent the
ICP-MS detector from damage during the time interval
that this compounds elutes from the column (18–22
min), the eluent was diverted from the ICP-MS. In this
sample, the presence of the MADG complex having a
retention time of 24.6 min is evident.
In the chromatogram shown in Figure 5b, the anal-
ysis of an aliquot from the reaction mixture (diluted
1:200 with nanopure water) after 3.5 h incubation is
presented. The peak with a retention time of 20.2 min
corresponds to ATG, as it matches that of its corre-
sponding standard.
Because the retention times of the complexes present
in standard solutions and the methylation reaction
mixture were similar (2% difference), it was not
necessary to conduct spiking experiments to confirm
their presence in the analyzed sample. In addition,
because of questionable compound stability, spiking
may not afford credible results.
Chromatographic recovery for the HPLC-ICP-MS
method was determined offline by fraction collection.
First, a mixture of the four As–GSH complexes was
gram of standard solutions of: (a) ATG (3.5
/mL), and (d) DMTAV–GSH (0.55 g/mL). Themato
.2 gond to impurities.
1566 KANAKI AND PERGANTIS J Am Soc Mass Spectrom 2008, 19, 1559–1567injected onto the HPLC system and the eluent was
collected for the entirety of the chromatographic run
(Fraction I). Second, injection of the same sample was
repeated, but without the HPLC column, and again the
analytes were collected (Fraction II). In both cases,
blank fractions consisting of mobile phase were col-
lected and used to correct for the arsenic background in
Fractions I and II. The arsenic response of all fractions
was measured using ICP-MS. The percentage chro-
matographic recovery for arsenic was calculated as:
 (blank corrected arsenic intensity of fraction I)(blank corrected arsenic intensity of fraction II)
 100
The calculated chromatographic recovery was 83%.
Estimated Limits of Detection for the Four
As–GSH Complexes Using HPLC-ICP-MS and
HPLC-ES-MS/MS Methods
To determine the limits of detection (LODs) for the four
As–GSH species using both HPLC-ICP-MS and HPLC-
Figure 5. Reversed-phase HPLC-ICP-MS chromatogram of the
arsenite methylation reaction mixture: (a) nondiluted aliquot after
2 h incubation at 37 °C and (b) diluted sample (1:200 with
deionized water) after 3.5 h incubation at 37 °C.ES-MS/MS-SRM methods, the standard solutions of
these species were serial-diluted in 0.1% formic acid
and analyzed. The LOD was considered the lowest
analyte concentration that produces a response three
times the chromatographic background noise level. The
resulting LODs, expressed as g As/L solution are
listed in Table 2.
As observed from Table 2, all four complexes exhibit
similar HPLC-ICP-MS LODs. The small differences that
are observed may be attributed to the applied gradient
program, during which the methanol content in the
mobile phase increases from 2% to 12% vol/vol. This
increase in the methanol amount causes variations in
the ICP-MS sensitivity and background.
With respect to the HPLC-ES-MS/MS-SRM method,
the LODs determined for the four As–GSH species
differ significantly. This is expected as it is well known
that the sensitivity and the LODs of this method are
species-dependent. Thus, arsenic compounds with dif-
ferent hydrophobicities, oxidation states, and degree of
methylation exhibit sensitivity and LOD variations.
The DMAG complex is detected at lower LODs using
HPLC-ES-MS/MS-SRM compared with using HPLC-
ICP-MS, which explains why this compound was de-
tectable as a product of the methylation reaction when
using the former technique and not detected using the
latter.
Conclusions
This study has demonstrated the development of mass
spectrometric techniques, i.e., HPLC-ES-MS/MS-SRM
and HPLC-ICP-MS, for the selective identification of
four As–GSH species (ATG, MADG, DMAG, and
DMTAV–GSH) in synthetic standard solutions. Further-
more, this methodology was applied to carry out a
preliminary study of the nonenzymatic methylation of
arsenite by methylcobalamin in the presence of gluta-
thione and for the first time the arsenic complexes ATG,
MADG, and DMAG were detected as products of this
reaction. These three species are possible intermediates
Table 2. Estimated LODs for the four As-GSH complexes
using HPLC-ICP-MS and HPLC-ES-MS/MS-SRM methods
Compound
% Vol/vol
methanol
contenta
LODs (g/L)
HPLC-ICP-
MS
HPLC-ES-MS/MS-SRM
(SRM transitionsb)
ATG 12 56 1123
MADG 12 26 210
DMAG 2 40 8
DMTAV-GSH 12 20 0.2
aMethanol content of mobile phase during the elution of each arsenic
species.
bSRM transitions used for each compound are given in Table 1.in the arsenic biomethylation process.
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